Upon the demonstration of nucleolin-mediated internalization of F3-peptide-targeted liposomes by lung cancer cell lines, the cytotoxic activity of encapsulated and free doxorubicin (used as a model of an anticancer drug) was assessed (Figure 6 and Table S5). The gene discussed is NUCLEOLIN; the disease is lung carcinoma.